FDA Inspection 1122446 — SpecGx, LLC
The FDA completed an inspection of SpecGx, LLC on March 16, 2020 in Webster Groves, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 16, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Webster Groves, MO (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)